Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment

References

• McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011;365(17):1567-75
   PubMed Web of Science ®Google Scholar
• Rodriguez-Roisin R, Drakulovic M, Rodriguez DA, et al. Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity. J Appl Physiol 2009;106(6):1902-8
   PubMed Web of Science ®Google Scholar
• Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187(4):347-65
   PubMed Web of Science ®Google Scholar
• Casanova C, Cote C, de Torres JP, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171(6):591-7
   PubMed Web of Science ®Google Scholar
• Zaman M, Mahmood S, Altayeh A. Low inspiratory capacity to total lung capacity ratio is a risk factor for chronic obstructive pulmonary disease exacerbation. Am J Med Sci 2010;339(5):411-14
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160(2):542-9
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Guenette JA, Maltais F, Webb KA. Decline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exercise. Chest 2012;141(3):753-62
   PubMed Web of Science ®Google Scholar
• Tzani P, Aiello M, Elia D, et al. Dynamic hyperinflation is associated with a poor cardiovascular response to exercise in COPD patients. Respir Res 2011;12:150
   PubMed Web of Science ®Google Scholar
• Watz H, Waschki B, Meyer T, et al. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest 2010;138(1):32-8
   PubMed Web of Science ®Google Scholar
• Loring SH, Garcia-Jacques M, Malhotra A. Pulmonary characteristics in COPD and mechanisms of increased work of breathing. J Appl Physiol 2009;107(1):309-14
   PubMed Web of Science ®Google Scholar
• Garcia-Rio F, Lores V, Mediano O, et al. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009;180(6):506-12
   PubMed Web of Science ®Google Scholar
• Lahaije AJ, van Helvoort HA, Dekhuijzen PN, et al. Resting and ADL-induced dynamic hyperinflation explain physical inactivity in COPD better than FEV1. Respir Med 2013;107(6):834-40
   Google Scholar
• Jones PW. Activity limitation and quality of life in COPD. COPD 2007;4(3):273-8
   PubMedGoogle Scholar
• Marin JM, Carrizo SJ, Gascon M, et al. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163(6):1395-9
   PubMed Web of Science ®Google Scholar
• Oga T, Nishimura K, Tsukino M, et al. Exercise capacity deterioration in patients with COPD: longitudinal evaluation over 5 years. Chest 2005;128(1):62-9
   PubMed Web of Science ®Google Scholar
• Pride NB, Macklem PT. Lung mechanics in disease. In: Fishman P, editor. Handbook of physiology, section 3: the respiratory system, mechanics of breathing, part 2 A. American Physiological Society; Bethesda, MD, USA: 1986. p. 659-92
   Google Scholar
• Brochard L. Intrinsic (or auto-) positive end-expiratory pressure during spontaneous or assisted ventilation. Intensive Care Med 2002;28(11):1552-4
   Google Scholar
• Albuquerque AL, Nery LE, Villaca DS, et al. Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III. Eur Respir J 2006;28(5):939-44
   PubMed Web of Science ®Google Scholar
• Guenette JA, Chin RC, Cory JM, et al. Inspiratory capacity during exercise: measurement, analysis, and interpretation. Pulm Med 2013;2013:e956081
   PubMedGoogle Scholar
• O’Donnell DE, Deesomchok A, Lam YM, et al. Effects of BMI on static lung volumes in patients with airway obstruction. Chest 2011;140(2):461-8
   PubMed Web of Science ®Google Scholar
• Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977;1(6077):1645-8
   PubMed Web of Science ®Google Scholar
• Celli BR, Decramer M, Lystig T, et al. Longitudinal inspiratory capacity changes in chronic obstructive pulmonary disease. Respir Res 2012;13:66
   Google Scholar
• Deesomchok A, Webb KA, Forkert L, et al. Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity. COPD 2010;7(6):428-37
   PubMedGoogle Scholar
• O’Donnell DE, Maltais F, Porszasz J, et al. The Continuum of Physiological Impairment during Treadmill Walking in Patients with Mild-to-Moderate COPD: patient Characterization Phase of a Randomized Clinical Trial. PLoS One 2014;9(5):e96574
   PubMed Web of Science ®Google Scholar
• Hogg JC, McDonough JE, Suzuki M. Small airway obstruction in COPD: new insights based on micro-CT imaging and MRI imaging. Chest 2013;143(5):1436-43
   PubMed Web of Science ®Google Scholar
• Mitzner W. Emphysema - a disease of small airways or lung parenchyma? N Engl J Med 2011;365(17):1637-9
   PubMed Web of Science ®Google Scholar
• Corbin RP, Loveland M, Martin RR, Macklem PT. A four-year follow-up study of lung mechanics in smokers. Am Rev Respir Dis 1979;120(2):293-304
   Google Scholar
• Yuan R, Hogg JC, Pare PD, et al. Prediction of the rate of decline in FEV(1) in smokers using quantitative Computed Tomography. Thorax 2009;64(11):944-9
   PubMed Web of Science ®Google Scholar
• Rambod M, Porszasz J, Make BJ, et al. Six-minute walk distance predictors, including CT scan measures, in the COPDGene cohort. Chest 2012;141(4):867-75
   PubMed Web of Science ®Google Scholar
• Washko GR, Dransfield MT, Estepar RS, et al. Airway wall attenuation: a biomarker of airway disease in subjects with COPD. J Appl Physiol 2009;107(1):185-91
   Google Scholar
• Barbosa EM Jr, Song G, Tustison N, et al. Computational analysis of thoracic multidetector row HRCT for segmentation and quantification of small airway air trapping and emphysema in obstructive pulmonary disease. Acad Radiol 2011;18(10):1258-69
   PubMed Web of Science ®Google Scholar
• Diaz AA, Morales A, Diaz JC, et al. CT and physiologic determinants of dyspnea and exercise capacity during the six-minute walk test in mild COPD. Respir Med 2013;107(4):570-9
   PubMed Web of Science ®Google Scholar
• Macklem PT. Therapeutic implications of the pathophysiology of COPD. Eur Respir J 2010;35(3):676-80
   PubMed Web of Science ®Google Scholar
• Parker CM, Voduc N, Aaron SD, et al. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J 2005;26(3):420-8
   PubMed Web of Science ®Google Scholar
• Stevenson NJ, Walker PP, Costello RW, Calverley PM. Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172(12):1510-16
   PubMed Web of Science ®Google Scholar
• Decramer M. Hyperinflation and respiratory muscle interaction. Eur Respir J 1997;10(4):934-41
   PubMed Web of Science ®Google Scholar
• Gorman RB, McKenzie DK, Pride NB, et al. Diaphragm length during tidal breathing in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166(11):1461-9
   PubMed Web of Science ®Google Scholar
• McKenzie DK, Butler JE, Gandevia SC. Respiratory muscle function and activation in chronic obstructive pulmonary disease. J Appl Physiol 2009;107(2):621-9
   Google Scholar
• Polkey MI, Kyroussis D, Hamnegard CH, et al. Diaphragm strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154(5):1310-17
   PubMed Web of Science ®Google Scholar
• Similowski T, Yan S, Gauthier AP, et al. Contractile properties of the human diaphragm during chronic hyperinflation. N Engl J Med 1991;325(13):917-23
   PubMed Web of Science ®Google Scholar
• Rochester DF, Braun NM. Determinants of maximal inspiratory pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 1985;132(1):42-7
   Google Scholar
• Clanton TL, Levine S. Respiratory muscle fiber remodeling in chronic hyperinflation: dysfunction or adaptation? J Appl Physiol 2009;107(1):324-35
   Google Scholar
• Bellemare F, Cordeau MP, Couture J, et al. Effects of emphysema and lung volume reduction surgery on transdiaphragmatic pressure and diaphragm length. Chest 2002;121(6):1898-910
   PubMed Web of Science ®Google Scholar
• Rochester DF. The diaphragm in COPD. Better than expected, but not good enough. N Engl J Med 1991;325(13):961-2
   PubMed Web of Science ®Google Scholar
• Levine S, Kaiser L, Leferovich J, Tikunov B. Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med 1997;337(25):1799-806
   PubMed Web of Science ®Google Scholar
• Levine S, Gregory C, Nguyen T, et al. Bioenergetic adaptation of individual human diaphragmatic myofibers to severe COPD. J Appl Physiol 2002;92(3):1205-13
   Google Scholar
• Orozco-Levi M, Gea J, Lloreta JL, et al. Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. Eur Respir J 1999;13(2):371-8
   PubMed Web of Science ®Google Scholar
• Barr RG, Bluemke DA, Ahmed FS, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010;362(3):217-27
   PubMed Web of Science ®Google Scholar
• Smith BM, Prince MR, Hoffman EA, et al. Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The Multi-Ethnic Study of Atherosclerosis COPD Study. Chest 2013;144(4):1143-51
   PubMed Web of Science ®Google Scholar
• Jorgensen K, Muller MF, Nel J, et al. Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI study. Chest 2007;131(4):1050-7
   PubMed Web of Science ®Google Scholar
• O’Donnell DE. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3(2):180-4
   PubMedGoogle Scholar
• O’Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158(5 Pt 1):1557-65
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Travers J, Webb KA, et al. Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD. Eur Respir J 2009;34(4):866-74
   PubMed Web of Science ®Google Scholar
• Stubbing DG, Pengelly LD, Morse JL, Jones NL. Pulmonary mechanics during exercise in subjects with chronic airflow obstruction. J Appl Physiol Respir Environ Exerc Physiol 1980;49(3):511-15
   PubMed Web of Science ®Google Scholar
• Vogiatzis I, Georgiadou O, Golemati S, et al. Patterns of dynamic hyperinflation during exercise and recovery in patients with severe chronic obstructive pulmonary disease. Thorax 2005;60(9):723-9
   Google Scholar
• Guenette JA, Webb KA, O’Donnell DE. Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD? Eur Respir J 2012;40(2):322-9
   PubMed Web of Science ®Google Scholar
• Laveneziana P, Webb KA, Ora J, et al. Evolution of dyspnea during exercise in chronic obstructive pulmonary disease: impact of critical volume constraints. Am J Respir Crit Care Med 2011;184(12):1367-73
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Hamilton AL, Webb KA. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD. J Appl Physiol 2006;101(4):1025-35
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164(5):770-7
   PubMed Web of Science ®Google Scholar
• Guenette JA, Jensen D, Webb KA, et al. Sex differences in exertional dyspnea in patients with mild COPD: physiological mechanisms. Respir Physiol Neurobiol 2011;177(3):218-27
   PubMed Web of Science ®Google Scholar
• Ofir D, Laveneziana P, Webb KA, et al. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177(6):622-9
   PubMed Web of Science ®Google Scholar
• Gelb AF, Gutierrez CA, Weisman IM, et al. Simplified detection of dynamic hyperinflation. Chest 2004;126(6):1855-60
   PubMed Web of Science ®Google Scholar
• Lahaije AJ, Willems LM, van Hees HW, et al. Diagnostic accuracy of metronome-paced tachypnea to detect dynamic hyperinflation. Clin Physiol Funct Imaging 2013;33(1):62-9
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Bertley JC, Chau LK, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 1997;155(1):109-15
   PubMed Web of Science ®Google Scholar
• Roussos C, Campbell EJM. Respiratory muscle energetics. In: Fishman P, editor. Handbook of physiology, section 3: The respiratory system, mechanics of breathing, part 2 A. American Physiological Society; Bethesda, MD, USA: 1986. p. 481-509
   Google Scholar
• Whipp BJ and Pardy RL. Breathing during exercise. In: Fishman P, editor. Handbook of physiology, section 3: the respiratory system, mechanics of breathing, part 2 A. American Physiological Society; Bethesda, MD, USA: 1986. p. 605-29
   Google Scholar
• De Troyer A, Wilson TA. Effect of acute inflation on the mechanics of the inspiratory muscles. J Appl Physiol 2009;107(1):315-23
   Google Scholar
• Decramer M. Effects of hyperinflation on the respiratory muscles. Eur Respir J 1989;2(4):299-302
   PubMed Web of Science ®Google Scholar
• LeBlanc P, Bowie DM, Summers E, et al. Breathlessness and exercise in patients with cardiorespiratory disease. Am Rev Respir Dis 1986;133(1):21-5
   PubMedGoogle Scholar
• Amann M, Regan MS, Kobitary M, et al. Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD. Am J Physiol Regul Integr Comp Physiol 2010;299(1):R314-24
   PubMed Web of Science ®Google Scholar
• Borghi-Silva A, Oliveira CC, Carrascosa C, et al. Respiratory muscle unloading improves leg muscle oxygenation during exercise in patients with COPD. Thorax 2008;63(10):910-15
   PubMed Web of Science ®Google Scholar
• Chiappa GR, Queiroga F Jr, Meda E, et al. Heliox improves oxygen delivery and utilization during dynamic exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;179(11):1004-10
   Google Scholar
• Chiappa GR, Vieira PJ, Umpierre D, et al. Inspiratory resistance decreases limb blood flow in COPD patients with heart failure. Eur Respir J 2014;43(5):1507-10
   Google Scholar
• O’Donnell DE, D’Arsigny C, Fitzpatrick M, Webb KA. Exercise hypercapnia in advanced chronic obstructive pulmonary disease: the role of lung hyperinflation. Am J Respir Crit Care Med 2002;166(5):663-8
   PubMed Web of Science ®Google Scholar
• Chiappa GR, Borghi-Silva A, Ferreira LF, et al. Kinetics of muscle deoxygenation are accelerated at the onset of heavy-intensity exercise in patients with COPD: relationship to central cardiovascular dynamics. J Appl Physiol 2008;104(5):1341-50
   PubMed Web of Science ®Google Scholar
• Montes de OM, Rassulo J, Celli BR. Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am J Respir Crit Care Med 1996;154(5):1284-9
   Google Scholar
• Vassaux C, Torre-Bouscoulet L, Zeineldine S, et al. Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J 2008;32(5):1275-82
   PubMed Web of Science ®Google Scholar
• Sliwinski P, Kaminski D, Zielinski J, Yan S. Partitioning of the elastic work of inspiration in patients with COPD during exercise. Eur Respir J 1998;11(2):416-21
   Google Scholar
• Chin RC, Guenette JA, Cheng S, et al. Does the respiratory system limit exercise in mild chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2013;187(12):1315-23
   PubMed Web of Science ®Google Scholar
• LeBlanc P, Summers E, Inman MD, et al. Inspiratory muscles during exercise: a problem of supply and demand. J Appl Physiol 1988;64(6):2482-9
   Google Scholar
• Decramer M. Response of the respiratory muscles to rehabilitation in COPD. J Appl Physiol 2009;107(3):971-6
   Google Scholar
• Polkey MI, Hamnegard CH, Hughes PD, et al. Influence of acute lung volume change on contractile properties of human diaphragm. J Appl Physiol 1998;85(4):1322-8
   PubMed Web of Science ®Google Scholar
• Mador MJ, Kufel TJ, Pineda LA, Sharma GK. Diaphragmatic fatigue and high-intensity exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161(1):118-23
   Google Scholar
• Polkey MI, Kyroussis D, Keilty SE, et al. Exhaustive treadmill exercise does not reduce twitch transdiaphragmatic pressure in patients with COPD. Am J Respir Crit Care Med 1995;152(3):959-64
   Google Scholar
• Hamilton N, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995;152:2021-31
   PubMed Web of Science ®Google Scholar
• Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158(2):629-34
   PubMed Web of Science ®Google Scholar
• Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996;153(3):976-80
   PubMed Web of Science ®Google Scholar
• Seymour JM, Spruit MA, Hopkinson NS, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 2010;36(1):81-8
   PubMed Web of Science ®Google Scholar
• Borghi-Silva A, Carrascosa C, Oliveira CC, et al. Effects of respiratory muscle unloading on leg muscle oxygenation and blood volume during high-intensity exercise in chronic heart failure. Am J Physiol Heart Circ Physiol 2008;294(6):H2465-72
   PubMed Web of Science ®Google Scholar
• Louvaris Z, Zakynthinos S, Aliverti A, et al. Heliox increases quadriceps muscle oxygen delivery during exercise in COPD patients with and without dynamic hyperinflation. J Appl Physiol 2012;113(7):1012-23
   PubMed Web of Science ®Google Scholar
• Dempsey JA, Romer L, Rodman J, et al. Consequences of exercise-induced respiratory muscle work. Respir Physiol Neurobiol 2006;151(2-3):242-50
   PubMed Web of Science ®Google Scholar
• Dempsey JA. Limits to ventilation (for sure!) and exercise (maybe?) in mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187(12):1282-3
   Google Scholar
• Scharf SM. Effects of normal and stressed inspiration on cardiovascular function. In: Scharf M, Cassidy SS, editors. Heart-lung interactions in health and disease S. Marcel Dekker; New York, NY, USA: 1989. p. 427-62
   Google Scholar
• Lloyd TC. Mechanical heart-lung interaction. In: Scharf M, Cassidy SS, editors. Heart-lung interactions in health and disease S. Marcel Dekker; New York, NY, USA: 1989. p. 309-38
   Google Scholar
• Light RW, Mintz HM, Linden GS, Brown SE. Hemodynamics of patients with severe chronic obstructive pulmonary disease during progressive upright exercise. Am Rev Respir Dis 1984;130(3):391-5
   Google Scholar
• Vizza CD, Lynch JP, Ochoa LL, et al. Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 1998;113(3):576-83
   PubMed Web of Science ®Google Scholar
• Morrison DA, Adcock K, Collins CM, et al. Right ventricular dysfunction and the exercise limitation of chronic obstructive pulmonary disease. J Am Coll Cardiol 1987;9(6):1219-29
   Google Scholar
• Vasilopoulou MK, Vogiatzis I, Nasis I, et al. On- and off-exercise kinetics of cardiac output in response to cycling and walking in COPD patients with GOLD Stages I-IV. Respir Physiol Neurobiol 2012;181(3):351-8
   Google Scholar
• Louvaris Z, Kortianou EA, Spetsioti S, et al. Intensity of daily physical activity is associated with central hemodynamic and leg muscle oxygen availability in COPD. J Appl Physiol 2013;115(6):794-802
   Google Scholar
• Kortianou EA, Louvaris Z, Vasilopoulou M, et al. Activity monitoring reflects cardiovascular and metabolic variations in COPD patients across GOLD stages II to IV. Respir Physiol Neurobiol 2013;189(3):513-20
   Google Scholar
• Berton DC, Barbosa PB, Takara LS, et al. Bronchodilators accelerate the dynamics of muscle O2 delivery and utilisation during exercise in COPD. Thorax 2010;65(7):588-93
   PubMed Web of Science ®Google Scholar
• Bronstad E, Tjonna AE, Rognmo O, et al. Aerobic exercise training improves right- and left ventricular systolic function in patients with COPD. COPD 2013;10(3):300-6
   Google Scholar
• Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012;185(4):435-52
   PubMed Web of Science ®Google Scholar
• Gandevia B, Hugh JP. Terminology for measurements of ventilatory capacity; a report to the thoracic society. Thorax 1957;12(4):290-3
   PubMedGoogle Scholar
• Moxham J, Jolley C. Breathlessness, fatigue and the respiratory muscles. Clin Med 2009;9(5):448-52
   PubMed Web of Science ®Google Scholar
• Sinderby C, Spahija J, Beck J, et al. Diaphragm activation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163(7):1637-41
   Google Scholar
• Luo YM, Hopkinson NS, Polkey MI. Tough at the top: must end-expiratory lung volume make way for end-inspiratory lung volume? Eur Respir J 2012;40(2):283-5
   Google Scholar
• O’Donnell DE, Hong HH, Webb KA. Respiratory sensation during chest wall restriction and dead space loading in exercising men. J Appl Physiol 2000;88(5):1859-69
   Google Scholar
• Schwartzstein RM, Simon PM, Weiss JW, et al. Breathlessness induced by dissociation between ventilation and chemical drive. Am Rev Respir Dis 1989;139(5):1231-7
   PubMedGoogle Scholar
• Harty HR, Corfield DR, Schwartzstein RM, Adams L. External thoracic restriction, respiratory sensation, and ventilation during exercise in men. J Appl Physiol 1999;86(4):1142-50
   PubMed Web of Science ®Google Scholar
• Banzett RB, Pedersen SH, Schwartzstein RM, Lansing RW. The affective dimension of laboratory dyspnea: air hunger is more unpleasant than work/effort. Am J Respir Crit Care Med 2008;177(12):1384-90
   Google Scholar
• Evans KC, Banzett RB, Adams L, et al. BOLD fMRI identifies limbic, paralimbic, and cerebellar activation during air hunger. J Neurophysiol 2002;88(3):1500-11
   Google Scholar
• Davenport PW, Vovk A. Cortical and subcortical central neural pathways in respiratory sensations. Respir Physiol Neurobiol 2009;167(1):72-86
   PubMed Web of Science ®Google Scholar
• Evans KC, Banzett RB, Adams L, et al. BOLD fMRI identifies limbic, paralimbic, and cerebellar activation during air hunger. J Neurophysiol 2002;88(3):1500-11
   Google Scholar
• Peiffer C, Poline JB, Thivard L, et al. Neural substrates for the perception of acutely induced dyspnea. Am J Respir Crit Care Med 2001;163(4):951-7
   Google Scholar
• Von Leupoldt A, Sommer T, Kegat S, et al. The unpleasantness of perceived dyspnea is processed in the anterior insula and amygdala. Am J Respir Crit Care Med 2008;177(9):1026-32
   PubMed Web of Science ®Google Scholar
• Von Leupoldt A, Sommer T, Kegat S, et al. Down-regulation of insular cortex responses to dyspnea and pain in asthma. Am J Respir Crit Care Med 2009;180(3):232-8
   PubMed Web of Science ®Google Scholar
• Von Leupoldt A, Brassen S, Baumann HJ, et al. Structural brain changes related to disease duration in patients with asthma. PLoS One 2011;6(8):e23739
   Google Scholar
• Lung function and patient preference with QVA149 vs. tiotropium in COPD patients (FAVOR). Available from: http://clinicaltrials.gov/show/NCT02125734
   Google Scholar
• The purpose of the this study is to evaluate the spirometric effect (trough FEV1) of umeclidinium/vilanterol 62.5/25 mcg once daily compared with tiotropium 18mcg once daily over a 12-week treatment period in subjects with COPD who continue to have symptoms on tiotropium. Available from: http://clinicaltrials.gov/show/NCT01899742
   Google Scholar
• Efficacy and safety of PT003, PT005, and PT001 in subjects with moderate to very severe COPD (PINNACLE 1). Available from: http://clinicaltrials.gov/show/NCT01854645
   Google Scholar
• Multi-center study to assess the efficacy and safety of PT003, PT005, and PT001 in subjects with moderate to very severe COPD (PINNACLE 2). Available from: http://clinicaltrials.gov/show/NCT01854658
   Google Scholar
• Effect of glycopyrronium on morning symptoms and pulmonary function in patients with moderate to severe COPD. Available from: http://clinicaltrials.gov/show/NCT01959516
   Google Scholar
• Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153(3):967-75
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Fluge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004;23(6):832-40
   PubMed Web of Science ®Google Scholar
• Cooper CB, Celli BR, Jardim JR, et al. Treadmill endurance during 2-year treatment with tiotropium in patients with COPD: a randomized trial. Chest 2013;144(2):490-7
   PubMed Web of Science ®Google Scholar
• RELOVAIR® Lung Deflation Study. Available from: http://clinicaltrials.gov/show/NCT01691885
   Google Scholar
• De Backer W, Devolder A, Poli G, et al. Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients. J Aerosol Med Pulm Drug Deliv 2010;23(3):137-48
   PubMed Web of Science ®Google Scholar
• Tzani P, Crisafulli E, Nicolini G, et al. Effects of beclomethasone/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients. Int J Chron Obstruct Pulmon Dis 2011;6:503-9
   PubMed Web of Science ®Google Scholar
• Singh D, Nicolini G, Bindi E, et al. Extrafine Beclomethasone/formoterol compared to Fluticasone/salmeterol Combination Therapy in COPD. BMC Pulm Med 2014;14:43
   PubMed Web of Science ®Google Scholar
• Calverley PM, Kuna P, Monso E, et al. Beclomethasone/formoterol in the management of COPD: a randomised controlled trial. Respir Med 2010;104(12):1858-68
   PubMed Web of Science ®Google Scholar
• Maltais F, Hamilton A, Marciniuk D, et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest 2005;128(3):1168-78
   PubMed Web of Science ®Google Scholar
• Scuarcialupi ME, Berton DC, Cordoni PK, et al. Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation? J Bras Pneumol 2014;40(2):111-18
   Google Scholar
• O’Donnell DE, Voduc N, Fitzpatrick M, Webb KA. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 2004;24(1):86-94
   PubMed Web of Science ®Google Scholar
• Peters MM, Webb KA, O’Donnell DE. Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD. Thorax 2006;61(7):559-67
   PubMed Web of Science ®Google Scholar
• Effect of a new combination bronchodilator on exercise in GOLD STage II moderate COPD. Available from: http://clinicaltrials.gov/show/NCT01491802
   Google Scholar
• To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways. Available from: http://clinicaltrials.gov/show/NCT02085161
   Google Scholar
• Effect on exercise endurance and lung hyperinflation of tiotropium + olodaterol in COPD patients. Available from: http://clinicaltrials.gov/show/NCT01533935
   Google Scholar
• van ’t Hul A, Kwakkel G, Gosselink R. The acute effects of noninvasive ventilatory support during exercise on exercise endurance and dyspnea in patients with chronic obstructive pulmonary disease: a systematic review. J Cardiopulm Rehabil 2002;22(4):290-7
   PubMedGoogle Scholar
• van ’t Hul A, Gosselink R, Hollander P, et al. Acute effects of inspiratory pressure support during exercise in patients with COPD. Eur Respir J 2004;23(1):34-40
   PubMed Web of Science ®Google Scholar
• O’Donnell DE. Ventilatory limitations in chronic obstructive pulmonary disease. Med Sci Sports Exerc 2001;33(7 Suppl):S647-55
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Sanii R, Younes M. Improvement in exercise endurance in patients with chronic airflow limitation using continuous positive airway pressure. Am Rev Respir Dis 1988;138(6):1510-14
   PubMed Web of Science ®Google Scholar
• Petrof BJ, Calderini E, Gottfried SB. Effect of CPAP on respiratory effort and dyspnea during exercise in severe COPD. J Appl Physiol 1990;69(1):179-88
   PubMed Web of Science ®Google Scholar
• Polkey MI, Kyroussis D, Mills GH, et al. Inspiratory pressure support reduces slowing of inspiratory muscle relaxation rate during exhaustive treadmill walking in severe COPD. Am J Respir Crit Care Med 1996;154(4 Pt 1):1146-50
   Google Scholar
• Maltais F, Reissmann H, Gottfried SB. Pressure support reduces inspiratory effort and dyspnea during exercise in chronic airflow obstruction. Am J Respir Crit Care Med 1995;151(4):1027-33
   PubMed Web of Science ®Google Scholar
• Ambrosino N, Strambi S. New strategies to improve exercise tolerance in chronic obstructive pulmonary disease. Eur Respir J 2004;24(2):313-22
   PubMed Web of Science ®Google Scholar
• Harms CA, Babcock MA, McClaran SR, et al. Respiratory muscle work compromises leg blood flow during maximal exercise. J Appl Physiol 1997;82(5):1573-83
   PubMed Web of Science ®Google Scholar
• Harms CA, Wetter TJ, St Croix CM, et al. Effects of respiratory muscle work on exercise performance. J Appl Physiol 2000;89(1):131-8
   PubMed Web of Science ®Google Scholar
• Bradley JM, Lasserson T, Elborn S, et al. A systematic review of randomized controlled trials examining the short-term benefit of ambulatory oxygen in COPD. Chest 2007;131(1):278-85
   Google Scholar
• Dolmage TE, Evans RA, Goldstein RS. Defining hyperinflation as ’dynamic’: moving toward the slope. Respir Med 2013;107(7):953-8
   Google Scholar
• Eves ND, Petersen SR, Haykowsky MJ, et al. Helium-hyperoxia, exercise, and respiratory mechanics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174(7):763-71
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, D’Arsigny C, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163(4):892-8
   PubMed Web of Science ®Google Scholar
• Somfay A, Porszasz J, Lee SM, Casaburi R. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. Eur Respir J 2001;18(1):77-84
   PubMed Web of Science ®Google Scholar
• Gagnon P, Bussieres JS, Ribeiro F, et al. Influences of spinal anesthesia on exercise tolerance in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;186(7):606-15
   PubMed Web of Science ®Google Scholar
• Palange P, Valli G, Onorati P, et al. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol 2004;97(5):1637-42
   PubMed Web of Science ®Google Scholar
• Hunt T, Williams MT, Frith P, Schembri D. Heliox, dyspnoea and exercise in COPD. Eur Respir Rev 2010;19(115):30-8
   Google Scholar
• Queiroga F Jr, Nunes M, Meda E, et al. Exercise tolerance with helium-hyperoxia versus hyperoxia in hypoxaemic patients with COPD. Eur Respir J 2013;42(2):362-70
   Google Scholar
• Hussain O, Collins EG, Adiguzel N, et al. Contrasting pressure-support ventilation and helium-oxygen during exercise in severe COPD. Respir Med 2011;105(3):494-505
   PubMed Web of Science ®Google Scholar
• Benditt JO, Wood DE, McCool FD, et al. Changes in breathing and ventilatory muscle recruitment patterns induced by lung volume reduction surgery. Am J Respir Crit Care Med 1997;155(1):279-84
   PubMed Web of Science ®Google Scholar
• Laghi F, Jubran A, Topeli A, et al. Effect of lung volume reduction surgery on neuromechanical coupling of the diaphragm. Am J Respir Crit Care Med 1998;157(2):475-83
   Google Scholar
• Martinez FJ, de Oca MM, Whyte RI, et al. Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med 1997;155(6):1984-90
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Webb KA, Bertley JC, et al. Mechanisms of relief of exertional breathlessness following unilateral bullectomy and lung volume reduction surgery in emphysema. Chest 1996;110(1):18-27
   Google Scholar
• Benditt JO, Lewis S, Wood DE, et al. Lung volume reduction surgery improves maximal O2 consumption, maximal minute ventilation, O2 pulse, and dead space-to-tidal volume ratio during leg cycle ergometry. Am J Respir Crit Care Med 1997;156(2 Pt 1):561-6
   Google Scholar
• Cordova F, O’Brien G, Furukawa S, et al. Stability of improvements in exercise performance and quality of life following bilateral lung volume reduction surgery in severe COPD. Chest 1997;112(4):907-15
   Google Scholar
• Keller CA, Ruppel G, Hibbett A, et al. Thoracoscopic lung volume reduction surgery reduces dyspnea and improves exercise capacity in patients with emphysema. Am J Respir Crit Care Med 1997;156(1):60-7
   Google Scholar
• Marchand E, Gayan-Ramirez G, De Leyn P, Decramer M. Physiological basis of improvement after lung volume reduction surgery for severe emphysema: where are we? Eur Respir J 1999;13(3):686-96
   Google Scholar
• Lacasse Y, Guyatt GH, Goldstein RS. The components of a respiratory rehabilitation program: a systematic overview. Chest 1997;111(4):1077-88
   PubMed Web of Science ®Google Scholar
• Casaburi R, Porszasz J. Reduction of hyperinflation by pharmacologic and other interventions. Proc Am Thorac Soc 2006;3(2):185-9
   PubMedGoogle Scholar
• Casaburi R, Zuwallack R. Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. N Engl J Med 2009;360(13):1329-35
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Ora J, Webb KA, et al. Mechanisms of activity-related dyspnea in pulmonary diseases. Respir Physiol Neurobiol 2009;167(1):116-32
   PubMed Web of Science ®Google Scholar
• Troosters T, Gosselink R, Janssens W, Decramer M. Exercise training and pulmonary rehabilitation: new insights and remaining challenges. Eur Respir Rev 2010;19(115):24-9
   PubMedGoogle Scholar
• Porszasz J, Emtner M, Goto S, et al. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest 2005;128(4):2025-34
   PubMed Web of Science ®Google Scholar
• Puente-Maestu L, Abad YM, Pedraza F, et al. A controlled trial of the effects of leg training on breathing pattern and dynamic hyperinflation in severe COPD. Lung 2006;184(3):159-67
   Google Scholar
• Casaburi R, Porszasz J, Burns MR, et al. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;155(5):1541-51
   PubMed Web of Science ®Google Scholar
• Wadell K, Webb KA, Preston ME, et al. Impact of pulmonary rehabilitation on the major dimensions of dyspnea in COPD. COPD 2013;10(4):425-35
   PubMedGoogle Scholar
• Casaburi R, Kukafka D, Cooper CB, et al. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 2005;127(3):809-17
   PubMed Web of Science ®Google Scholar
• Spahija J, Marchie M, Ghezzo H, Grassino A. Factors discriminating spontaneous pursed-lips breathing use in patients with COPD. COPD 2010;7(4):254-61
   PubMedGoogle Scholar
• Casciari RJ, Fairshter RD, Harrison A, et al. Effects of breathing retraining in patients with chronic obstructive pulmonary disease. Chest 1981;79(4):393-8
   Google Scholar
• Garrod R, Dallimore K, Cook J, et al. An evaluation of the acute impact of pursed lips breathing on walking distance in nonspontaneous pursed lips breathing chronic obstructive pulmonary disease patients. Chron Respir Dis 2005;2(2):67-72
   PubMedGoogle Scholar
• Nield MA, Soo Hoo GW, Roper JM, Santiago S. Efficacy of pursed-lips breathing: a breathing pattern retraining strategy for dyspnea reduction. J Cardiopulm Rehabil Prev 2007;27(4):237-44
   PubMed Web of Science ®Google Scholar
• Pomidori L, Campigotto F, Amatya TM, et al. Efficacy and tolerability of yoga breathing in patients with chronic obstructive pulmonary disease: a pilot study. J Cardiopulm Rehabil Prev 2009;29(2):133-7
   Google Scholar
• Collins EG, Langbein WE, Fehr L, et al. Can ventilation-feedback training augment exercise tolerance in patients with chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2008;177(8):844-52
   Google Scholar
• Gosselink R, De Vos J, van den Heuvel SP, et al. Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J 2011;37(2):416-25
   PubMed Web of Science ®Google Scholar
• Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188(8):e13-64
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Sanii R, Giesbrecht G, Younes M. Effect of continuous positive airway pressure on respiratory sensation in patients with chronic obstructive pulmonary disease during submaximal exercise. Am Rev Respir Dis 1988;138(5):1185-91
   PubMed Web of Science ®Google Scholar
• Petrovic M, Reiter M, Zipko H, et al. Effects of inspiratory muscle training on dynamic hyperinflation in patients with COPD. Int J Chron Obstruct Pulmon Dis 2012;7:797-805
   PubMed Web of Science ®Google Scholar
• Ramirez-Sarmiento A, Orozco-Levi M, Guell R, et al. Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes. Am J Respir Crit Care Med 2002;166(11):1491-7
   PubMed Web of Science ®Google Scholar
• Villafranca C, Borzone G, Leiva A, Lisboa C. Effect of inspiratory muscle training with an intermediate load on inspiratory power output in COPD. Eur Respir J 1998;11(1):28-33
   Google Scholar
• O’Donnell DE. Impacting patient-centred outcomes in COPD: breathlessness and exercise tolerance. Eur Respir Rev 2006;15(99):37-41
   Google Scholar
• Man WD, Mustfa N, Nikoletou D, et al. Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD. Thorax 2004;59:471-6
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Sciurba F, Celli B, et al. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest 2006;130:647-56
   PubMed Web of Science ®Google Scholar
• Neder JA, Fuld JP, Overend T, et al. Effects of formoterol on exercise tolerance in severely disabled patients with COPD. Respir Med 2007;101:2056-64
   PubMed Web of Science ®Google Scholar
• Worth H, Forster K, Eriksson G, et al. Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD. Respir Med 2010;104:1450-9
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Casaburi R, Vincken W, et al. on behalf of INABLE study investigators. Effect of indacaterol on exercise endurance and lung hyperinflation in COPD. Respir Med 2011;105(7):1030-6
   PubMed Web of Science ®Google Scholar
• Beeh KM, Wagner F, Khindri S, Drollmann AF. Effect of indacaterol on dynamic lung hyperinflation and breathlessness in hyperinflated patients with COPD. COPD 2011;8:340-5
   PubMedGoogle Scholar
• O’Donnell DE, Flüge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004;23(6):832-40
   PubMed Web of Science ®Google Scholar
• Maltais F, Celli B, Casaburi R, et al. Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD. Respir Med 2011;105(4):580-7
   PubMed Web of Science ®Google Scholar
• Beeh KM, Sing D, Di Scala L, Drollmann A. Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial. Int J COPD 2012;7:503-13
   Google Scholar
• Beeh KM, Korn S, Beier J, et al. Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: the BRIGHT study. Respir Med 2014;108(4):584-92
   PubMed Web of Science ®Google Scholar